ReviewGigaScience2026
Harnessing artificial intelligence for genomic variant prediction: advances, challenges, and future directions.
Review in GigaScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ChatMDV: reducing technical barriers in bioinformatics analysis using large language models.GigaScience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate genetic variant interpretation is crucial for disease research and the development of targeted therapies. Artificial intelligence is transforming this field by integrating computational methodologies across structural biology, evolutionary analysis, and multimodal genomic data. This review examines the evolution from traditional rule-based systems and statistical models to contemporary machine learning, deep learning, and protein language models, while addressing critical challenges in variant classification. Key obstacles include data heterogeneity, interpretability, and the persistence of variants of uncertain significance, emphasizing the critical need for explainable artificial intelligence frameworks and more inclusive genomic databases to improve predictive accuracy across diverse populations. Based on the assessment of current variant impact predictors, we propose strategies for enhanced predictor selection, effective multi-omics data integration, and optimized computational workflows. These recommendations aim to enhance variant interpretation accuracy in both research settings and clinical practice, ultimately contributing to advances in personalized medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.